Advestra advises UBS Switzerland AG and the other members of the banking syndicate on the EUR 200 million financing of Swixx Biopharma’s acquisition of Laboratorios Biopas

Advestra advised UBS Switzer­land AG as man­dated lead arranger, coordinator, agent, security agent and lender togeth­er with the oth­er syn­dic­ate banks as lenders on the EUR 200 million cred­it facil­it­ies provided to Swixx Biopharma AG, one of the fastest-growing, largest, independent, intercontinental commercial platforms for the biopharmaceutical industry, for the acquis­i­tion of Laboratorios Biopas.

Advestra acted as lead leg­al coun­sel to the bank­ing syn­dic­ate in the trans­ac­tion. The team included Alex­an­der von Jein­sen, Annina Hammer, Alexander Fisch and Martina Giacometti (all Fin­an­cing) as well as Céline Mar­tin (Tax).